Cargando…
P1084: LONG-TERM EFFICACY AND SAFETY OF ZANUBRUTINIB (ZANU) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): FINAL ANALYSIS OF THE MAGNOLIA (BGB-3111-214) TRIAL
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430945/ http://dx.doi.org/10.1097/01.HS9.0000971232.77003.b0 |
| _version_ | 1785091081416736768 |
|---|---|
| author | Opat, Stephen Tedeschi, Alessandra Hu, Bei Linton, Kim Mckay, Pam Leitch, Sophie Jin, Jie Sun, Mingyuan Sobieraj-Teague, Magdalena Luigi Zinzani, Pier Browett, Peter Thieblemont, Catherine Marina Liberati, Anna Bachy, Emmanuel Cavallo, Federica Costello, Régis Iyengar, Sunil Marasca, Roberto Mociková, Heidi Seok Kim, Jin Talaulikar, Dipti Liang, Zhiyu Xu, Jianfeng Tankersley, Chris Delarue, Richard Co, Melannie Trotman, Judith |
| author_facet | Opat, Stephen Tedeschi, Alessandra Hu, Bei Linton, Kim Mckay, Pam Leitch, Sophie Jin, Jie Sun, Mingyuan Sobieraj-Teague, Magdalena Luigi Zinzani, Pier Browett, Peter Thieblemont, Catherine Marina Liberati, Anna Bachy, Emmanuel Cavallo, Federica Costello, Régis Iyengar, Sunil Marasca, Roberto Mociková, Heidi Seok Kim, Jin Talaulikar, Dipti Liang, Zhiyu Xu, Jianfeng Tankersley, Chris Delarue, Richard Co, Melannie Trotman, Judith |
| author_sort | Opat, Stephen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430945 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104309452023-08-17 P1084: LONG-TERM EFFICACY AND SAFETY OF ZANUBRUTINIB (ZANU) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): FINAL ANALYSIS OF THE MAGNOLIA (BGB-3111-214) TRIAL Opat, Stephen Tedeschi, Alessandra Hu, Bei Linton, Kim Mckay, Pam Leitch, Sophie Jin, Jie Sun, Mingyuan Sobieraj-Teague, Magdalena Luigi Zinzani, Pier Browett, Peter Thieblemont, Catherine Marina Liberati, Anna Bachy, Emmanuel Cavallo, Federica Costello, Régis Iyengar, Sunil Marasca, Roberto Mociková, Heidi Seok Kim, Jin Talaulikar, Dipti Liang, Zhiyu Xu, Jianfeng Tankersley, Chris Delarue, Richard Co, Melannie Trotman, Judith Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430945/ http://dx.doi.org/10.1097/01.HS9.0000971232.77003.b0 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Opat, Stephen Tedeschi, Alessandra Hu, Bei Linton, Kim Mckay, Pam Leitch, Sophie Jin, Jie Sun, Mingyuan Sobieraj-Teague, Magdalena Luigi Zinzani, Pier Browett, Peter Thieblemont, Catherine Marina Liberati, Anna Bachy, Emmanuel Cavallo, Federica Costello, Régis Iyengar, Sunil Marasca, Roberto Mociková, Heidi Seok Kim, Jin Talaulikar, Dipti Liang, Zhiyu Xu, Jianfeng Tankersley, Chris Delarue, Richard Co, Melannie Trotman, Judith P1084: LONG-TERM EFFICACY AND SAFETY OF ZANUBRUTINIB (ZANU) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): FINAL ANALYSIS OF THE MAGNOLIA (BGB-3111-214) TRIAL |
| title | P1084: LONG-TERM EFFICACY AND SAFETY OF ZANUBRUTINIB (ZANU) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): FINAL ANALYSIS OF THE MAGNOLIA (BGB-3111-214) TRIAL |
| title_full | P1084: LONG-TERM EFFICACY AND SAFETY OF ZANUBRUTINIB (ZANU) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): FINAL ANALYSIS OF THE MAGNOLIA (BGB-3111-214) TRIAL |
| title_fullStr | P1084: LONG-TERM EFFICACY AND SAFETY OF ZANUBRUTINIB (ZANU) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): FINAL ANALYSIS OF THE MAGNOLIA (BGB-3111-214) TRIAL |
| title_full_unstemmed | P1084: LONG-TERM EFFICACY AND SAFETY OF ZANUBRUTINIB (ZANU) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): FINAL ANALYSIS OF THE MAGNOLIA (BGB-3111-214) TRIAL |
| title_short | P1084: LONG-TERM EFFICACY AND SAFETY OF ZANUBRUTINIB (ZANU) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): FINAL ANALYSIS OF THE MAGNOLIA (BGB-3111-214) TRIAL |
| title_sort | p1084: long-term efficacy and safety of zanubrutinib (zanu) in patients (pts) with relapsed/refractory (r/r) marginal zone lymphoma (mzl): final analysis of the magnolia (bgb-3111-214) trial |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430945/ http://dx.doi.org/10.1097/01.HS9.0000971232.77003.b0 |
| work_keys_str_mv | AT opatstephen p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT tedeschialessandra p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT hubei p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT lintonkim p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT mckaypam p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT leitchsophie p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT jinjie p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT sunmingyuan p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT sobierajteaguemagdalena p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT luigizinzanipier p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT browettpeter p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT thieblemontcatherine p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT marinaliberatianna p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT bachyemmanuel p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT cavallofederica p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT costelloregis p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT iyengarsunil p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT marascaroberto p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT mocikovaheidi p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT seokkimjin p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT talaulikardipti p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT liangzhiyu p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT xujianfeng p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT tankersleychris p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT delaruerichard p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT comelannie p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial AT trotmanjudith p1084longtermefficacyandsafetyofzanubrutinibzanuinpatientsptswithrelapsedrefractoryrrmarginalzonelymphomamzlfinalanalysisofthemagnoliabgb3111214trial |